Resistance prediction in high‐grade serous ovarian carcinoma with neoadjuvant chemotherapy using data‐independent acquisition proteomics and an ovary‐specific spectral library

High‐grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian cancer with 5‐year survival rates below 40%. Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is recommended for patients with advanced‐stage HGSOC unsuitable for primary debulking surgery (...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Liujia, Zhu, Jianqing, Xue, Zhangzhi, Gong, Tingting, Xiang, Nan, Yue, Liang, Cai, Xue, Gong, Wangang, Wang, Junjian, Sun, Rui, Jiang, Wenhao, Ge, Weigang, Wang, He, Zheng, Zhiguo, Wu, Qijun, Zhu, Yi, Guo, Tiannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399723/
https://www.ncbi.nlm.nih.gov/pubmed/36855266
http://dx.doi.org/10.1002/1878-0261.13410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399723/
https://www.ncbi.nlm.nih.gov/pubmed/36855266
http://dx.doi.org/10.1002/1878-0261.13410

Ejemplares similares